EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Escalation of CTX-M-producing extensively drug-resistant Shigella spp. in Kolkata, India, following the COVID-19 pandemic

Puja Bose iD, Gourab Halder iD, Pratanu Kayet, Goutam Chowdhury iD, Surajit Basak, Deboleena Roy, Daisuke Imamura, Shin-Ichi Miyoshi iD, Masatomo Morita iD, Thandavarayan Ramamurthy iD, Hemanta Koley, Santasabuj Das iD und 1 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02824-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Puja Bose und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India. Hauptthemen laut MEDLINE: Shigella, Drug Resistance, Multiple, Bacterial, beta-Lactamases, Dysentery, Bacillary. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shigella spp. is recognized by the World Health Organization as a high-priority pathogen due to its global prevalence, unique pathogenic mechanisms, and growing antimicrobial resistance (AMR). Nearly half of all Shigella strains worldwide are now multidrug-resistant (MDR), and the emergence of extensively drug-resistant (XDR) variants—resistant to ciprofloxacin, ceftriaxone, and azithromycin—has severely limited effective treatment options. The present study is based on prospective laboratory surveillance involving 323 Shigella isolates collected during 2021–2023, with pre-COVID-19 pandemic data included from a previously published study solely for historical comparison. The presence of antibiotic resistance genes (ARGs) was investigated, and whole-genome sequencing (WGS) was performed on representative isolates to assess phylogenetic relatedness with global isolates. Approximately 10% of isolates exhibited resistance to third-generation cephalosporins. While only 3% of Shigella isolates carried the bla CTX-M-15 gene from 2013 to 2019, its prevalence increased to 26% by 2022–2023. Among 38 ceftriaxone-resistant S. sonnei isolates, 33 were also resistant to azithromycin, categorizing them as XDR. These isolates showed 48% clonal similarity and high phylogenetic resemblance to the isolates reported from England. Hybrid genome assembly revealed a plasmid harboring both the bla CTX-M-15 and mphA ARGs. Conjugation experiments and plasmid profiling confirmed the plasmid’s transferability. We report a rising trend in third-generation cephalosporin resistance among Shigella spp., primarily driven by the spread of extended-spectrum β-lactamase-producing S. flexneri and the emergence of XDR S. sonnei . These findings underscore the urgent need for strengthened national AMR containment strategies and enhanced international surveillance of cephalosporin-resistant Shigella to mitigate this growing public health threat. IMPORTANCE Shigella is a leading cause of diarrheal disease globally and has been prioritized by the World Health Organization due to its rapid acquisition of antimicrobial resistance. Our prospective surveillance in Kolkata, India, reveals a worrisome escalation of third-generation cephalosporin resistance over the past decade, primarily associated with the spread of bla CTX-M-15 and the emergence of extensively drug-resistant (XDR) S. sonnei . The detection of plasmids carrying both bla CTX-M-15 and mphA , coupled with evidence of their transferability, highlights the potential for accelerated dissemination of multidrug resistance. When compared with a global data set of international genomes, the Kolkata XDR isolates were found to cluster closely with isolates reported from England. By linking local surveillance with global genomic context, our findings provide critical insights for treatment guidelines, antimicrobial stewardship, and the design of international containment strategies aimed at curbing the rise of cephalosporin- and azithromycin-resistant Shigella .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ShigellaDrug Resistance, Multiple, Bacterialbeta-LactamasesDysentery, BacillaryIndiaAnti-Bacterial AgentsHumansThird Generation CephalosporinsWhole Genome SequencingPhylogenyMicrobial Sensitivity TestsCiprofloxacinSARS-CoV-2PlasmidsPandemicsBacterial ProteinsAzithromycinCeftriaxone

Stichwörter der Autor:innen

AMRCTX-MPFGEShigella spp.WGSXDRdysenteryplasmidtransconjugants

Substanzen

Anti-Bacterial Agentsbeta-LactamasesThird Generation CephalosporinsCiprofloxacinBacterial ProteinsAzithromycinCeftriaxone

Autor:innen und Institutionen

  • Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
  • Division of Bioinformatics, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
  • Collaborative Research Centre of Okayama University for Infectious Diseases at ICMR-NIRBI, Kolkata, India.
  • Research Center for Intestinal Health Science, Okayama University, Okayama, Japan.
  • Department of Bacteriology I, National Institute of Infectious Diseases, Shinjuku City, Tokyo, Japan.
  • Division of Clinical Medicine, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.

ORCID-Profile: Puja Bose, Gourab Halder, Goutam Chowdhury, Shin-Ichi Miyoshi, Masatomo Morita, Thandavarayan Ramamurthy, Santasabuj Das, Asish Kumar Mukhopadhyay

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Bose, P., Halder, G., Kayet, P., Chowdhury, G., Basak, S., Roy, D., Imamura, D., Miyoshi, S., Morita, M., Ramamurthy, T., Koley, H., Das, S., & Mukhopadhyay, A. K. (2026). Escalation of CTX-M-producing extensively drug-resistant Shigella spp. in Kolkata, India, following the COVID-19 pandemic. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02824-25

Vancouver

Bose P, Halder G, Kayet P, Chowdhury G, Basak S, Roy D, et al. Escalation of CTX-M-producing extensively drug-resistant Shigella spp. in Kolkata, India, following the COVID-19 pandemic. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02824-25

BibTeX
@article{Bose2026,
  author = {Bose, Puja and Halder, Gourab and Kayet, Pratanu and Chowdhury, Goutam and Basak, Surajit and Roy, Deboleena and Imamura, Daisuke and Miyoshi, Shin-Ichi and Morita, Masatomo and Ramamurthy, Thandavarayan and Koley, Hemanta and Das, Santasabuj and Mukhopadhyay, Asish Kumar},
  title = {Escalation of CTX-M-producing extensively drug-resistant Shigella spp. in Kolkata, India, following the COVID-19 pandemic},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02824-25}
}
Kostenlos starten →